Document And Entity Information
Document And Entity Information | Jul. 19, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jul. 19, 2022 |
Entity Registrant Name | Inozyme Pharma, Inc. |
Entity Central Index Key | 0001693011 |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity File Number | 001-39397 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 38-4024528 |
Entity Address, Address Line One | 321 Summer Street |
Entity Address, Address Line Two | Suite 400 |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02210 |
City Area Code | 857 |
Local Phone Number | 330-4340 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, par value $0.0001 per share |
Trading Symbol | INZY |
Security Exchange Name | NASDAQ |